Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
asparaginase (elspar) (2 trials)
cyclophosphamide (cytoxan) (2 trials)
cytarabine (cytosar-u) (2 trials)
daunorubicin (cerubidine) (2 trials)
etoposide (vepesid) (2 trials)
mercaptopurine (purinethol) (2 trials)
naltrexone (revia) (2 trials)
prednisone (meticorten) (2 trials)
tioguanine (Lanvis) (2 trials)
urea (2 trials)
vincristine (oncovin) (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
autologous umbilical cord blood (1 trial)
busulfan (Myleran) (1 trial)
cyclosporine (sandimmune) (1 trial)
leucovorin (1 trial)
melphalan (alkeran) (1 trial)
mitoxantrone (novantrone) (1 trial)
pegaspargase (oncaspar) (1 trial)
Lymphoma (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Trials (2 total)
Trial APIs (20 total)